Kate Hopkins, PhD, MPH

Dr. Kate Hopkins oversees the research programming across the Vaccine Acceptance & Demand team to implement program activities, expand and manage partnerships, invest in new research projects and continue the growth of Sabin’s thought leadership programming.

Prior to joining Sabin, Kate spent 11 years living and working in sub-Saharan Africa conducting infectious disease prevention and psychosocial-behavioral research and health service program implementation in low- and middle-income countries—with particular focus on high-risk and vulnerable populations. Managing multi-country and multidisciplinary teams, her past portfolio of work included supporting clinical research site operations and strengthening capacity for the conduct of HIV and COVID-19 vaccine clinical trials within the HIV Vaccine Trials Network and COVID-19 Prevention Network. Kate supported the implementation of the ENSEMBLE J&J Phase III clinical trial and the subsequent SISONKE J&J COVID-19 vaccination rollout amongst healthcare workers in South Africa.

Kate has been a joint-Faculty Researcher for the Faculty of Health Sciences, University of the Witwatersrand in Johannesburg, South Africa, for nine years; and is a virtual course lecturer on Operational Research within a post-graduate diploma program in TB/HIV Management for the University of Cape Town in South Africa. She was awarded funding for her PhD study from the CDC as a PEPFAR-funded activity under its Cooperative Agreement with the South African Medical Research Council, earning her degree from the University of the Witwatersrand School of Public Health. She also holds a Masters in Public Health, with a focus on Global Health, from Boston University School of Public Health.